On the public citation graph
On Quality Standards and the Timing of Pharmaceutical Investment
0 signed · 15 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/978-3-7643-7390-0_3openalex-extracted
Optimal stopping and free-boundary problems
inferredcites →https://doi.org/10.1016/j.econlet.2013.02.018openalex-extracted
Implementation lag and the investment decision
inferredcites →https://doi.org/10.1016/j.ejor.2021.07.003openalex-extracted
Optimal investment and abandonment decisions for projects with construction uncertainty
inferredcites →https://doi.org/10.1016/j.ejor.2022.06.034openalex-extracted
Optimal timing of non-pharmaceutical interventions during an epidemic
inferredcites →https://doi.org/10.1016/j.jedc.2015.06.001openalex-extracted
A model for irreversible investment with construction and revenue uncertainty
inferredcites →https://doi.org/10.1016/j.respol.2005.12.005openalex-extracted
Application of real options analysis for pharmaceutical R&D project valuation—Empirical results from a survey
inferredcites →https://doi.org/10.1016/s0048-7333(99)00061-xopenalex-extracted
The contrasting roles of government in the development of biotechnology industry in the US and Germany
inferredcites →https://doi.org/10.1016/s0165-1889(99)00005-6openalex-extracted
On the investment–uncertainty relationship in a real options model
inferredcites →https://doi.org/10.1017/s1744133107004392openalex-extracted
Global public–private partnerships against neglected diseases: building governance structures for effective outcomes
inferredcites →https://doi.org/10.1038/clpt.2012.83openalex-extracted
The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases
inferredcites →https://doi.org/10.1086/256964openalex-extracted
Vertical Integration and Antitrust Policy
inferredcites →https://doi.org/10.1109/tac.2006.882767openalex-extracted
Stochastic Differential Equations—An Introduction With Applications
inferredcites →https://doi.org/10.1186/s12992-022-00851-3openalex-extracted
“No Regrets” Purchasing in a pandemic: making the most of advance purchase agreements
inferredcites →https://doi.org/10.1377/hlthaff.24.3.653openalex-extracted
Vaccine Advance-Purchase Agreements For Low-Income Countries: Practical Issues
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.